1. Introduction {#sec1}
===============

Adrenal myelolipoma (AML) is a relatively rare benign tumor composed of mature adipose tissues and a variable amount of hematopoietic elements. The male-to-female ratio is 1 : 1. The incidence of AML is reported to be 0.08--0.4% at autopsy \[[@B1]\]. AMLs are nonfunctional tumors that are usually asymptomatic; however, they have been known to coexist with other endocrine disorders, such as Cushing\'s syndrome, congenital adrenal hyperplasia (CAH), Conn\'s syndrome, and pheochromocytoma \[[@B2]--[@B4]\]. Recently, AMLs have been reported in patients with CAH with increasing frequency. One study indicated that myelolipoma was detected in 4% of patients with CAH \[[@B5]\].

The largest AML (size, 31 × 24.5 × 11.5 cm; weight, 6000 g) in a patient without endocrine disorder was described by Akamatsu et al. \[[@B6]\], while the largest AML in a patient with CAH (size, 34 × 24 × 10.5 cm; weight, 5900 g) was described by Boudreaux et al. \[[@B7]\].

We herein report a relatively rare case of a giant AML of 1500 g in weight in a patient without endocrine disorder and discuss our analysis of the literature.

2. Case Report {#sec2}
==============

A 62-year-old Japanese female patient presented with a left abdominal mass. She was referred to our surgical outpatient clinic to undergo a detailed examination and treatment for the left abdominal mass. A clinical examination revealed an elastic soft, smooth-surfaced, painless, child-head-sized tumor with poor mobility, which was located in the left upper abdomen. Abdominal computed tomography (CT) demonstrated a child-head-sized mass with heterogeneous contrast at the left upper abdomen around the stomach, spleen, pancreas, and left kidney on a horizontal image ([Figure 1(a)](#fig1){ref-type="fig"}) and coronal image ([Figure 1(b)](#fig1){ref-type="fig"}).

Magnetic resonance imaging (MRI) revealed a heterogeneously hyperintense mass on T1-weighted imaging ([Figure 2(a)](#fig2){ref-type="fig"}), a relatively uniform and hyperintense mass on T2-weighted imaging ([Figure 2(b)](#fig2){ref-type="fig"}), and a hypointense mass with an enhanced border on gadolinium- (Gd-) enhanced imaging ([Figure 2(c)](#fig2){ref-type="fig"}). A retroperitoneal tumor was diagnosed. Her laboratory data were white blood cell count, 4600/mm^3^; hemoglobin, 12.8 g/dl; hematocrit, 36.5%; and platelet count, 182,000/mm^3^, with normal electrolytes, as well as normal blood urea nitrogen levels, but slight liver dysfunction. Her serum levels of corticosteroid and/or androgen were 13.3 ng/ml (10.4--35.0 in female) and 173 pg/dl (35.7--240.0), respectively, which are within the normal ranges; however, her serum level of ACTH was elevated at 138.70 pg/ml (7.2--63.3).

The retroperitoneal tumor was resected ([Figure 3](#fig3){ref-type="fig"}). The tumor was located at the left side of the stomach, posteriorly to the transverse mesocolon and pancreas, on the cranial side of the left kidney (Figures [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}), but has not invaded the surrounding organs (Figures [1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). The right adrenal gland was normal in size. The resected tumor was 20 × 18 × 10 cm in diameter and weighted 1500 g. An examination of the cut surface of the tumor revealed a multilobular yellow mass with bleeding in places ([Figure 4](#fig4){ref-type="fig"}).

A histopathological examination with hematoxylin and eosin staining revealed that the tumor was composed of a proliferation of mature and variable-sized adipocytes admixed with aggregates of hematopoietic elements, associated with adrenal gland tissue in the peripheral region within the tumor ([Figure 5](#fig5){ref-type="fig"}). These findings were compatible with AML.

The patient had an uneventful recovery and was discharged from the hospital on the 6th day after the operation. She has been followed up in our outpatient clinic without recurrence for approximately 12 years since undergoing the operation.

3. Discussion {#sec3}
=============

The etiology of AML remains unclear. Some of the hypothesized etiologies include extramedullary hematopoiesis due to the autonomous proliferation of bone marrow cells transferred during embryogenesis, degeneration of epithelial tissues of the adrenal cortex, and adrenocortical cell metaplasia of the reticuloendothelial cells of the blood capillaries in response to stimuli such as necrosis, infection, or stress \[[@B1], [@B8]--[@B10]\]. The most widely accepted theory is that myelolipomas arise due to metaplasia of the reticuloendothelial cells of the blood capillaries in the adrenal gland in response to stimuli such as chronic stress, infection, necrosis, or inflammation \[[@B11], [@B12]\].

Although the diameter of AMLs ranges from less than 1 cm to more than 30 cm, they are usually less than 5 cm in diameter \[[@B13], [@B14]\]. AML is often asymptomatic, sometimes leading to very large adrenal masses (≧10 cm in diameter). These are often called "giant AML" \[[@B15]\]. Lawler et al. proposed a definition of the often quoted term "giant" AML \[[@B16]\]. We propose that giant AMLs of ≧1, 500 g should be called "real giant AMLs." According to this criterion, we found the 21 cases involving giant AMLs in patients without endocrine disorders ([Table 1](#tab1){ref-type="table"}) and the 6 cases involving giant AMLs in patients with CAH ([Table 2](#tab2){ref-type="table"}).

Ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI) are effective for diagnosing AML in ≧90% of cases \[[@B4], [@B17]\]. Recently, with the widespread use of imaging studies such as US, CT, and MRI, the incidental detection of AML has been more common, and they now represent up to 10--15% of incidentally detected adrenal masses \[[@B18]\]. US shows myelolipoma as a well-defined tumor with varying degrees of hyperechoic (fatty tissue) and hypoechoic (myeloid tissue) components. CT shows myelolipoma as a well-delineated mass with heterogeneous attenuation and low-density fat tissue with more dense areas of myeloid tissue. MRI demonstrates myelolipoma as an area of high signal intensity on T1-weighted and T2-weighted sequences with reduced signal intensity on fat suppression and opposite phase imaging \[[@B18], [@B19]\].

Management of AML should be individualized. Small lesions, which are asymptomatic and measure less than 5 cm, should be monitored over a period of 1-2 years with imaging controls \[[@B20]\]. On the other hand, surgery is indicated when the patient is symptomatic, when the lesion is more than 5 cm in size due to rupture---which is a rare event---or when malignancy is suspected \[[@B20]\]. The most recognized complication of AML is spontaneous retroperitoneal hemorrhage \[[@B14], [@B16]\]. Daneshmand et al. suggested that symptomatic tumors or myelolipomas of ≧7 cm in size should be removed because they are associated with an increased risk of spontaneous rupture with retroperitoneal hemorrhage \[[@B4]\].

4. Conclusion {#sec4}
=============

We reported a relatively rare case of a real giant AML that weighted 1500 g in a patient without an endocrine disorder. It is very important to provide suitable management on an individual basis.
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![Abdominal computed tomography (CT) demonstrated a child-head-sized mass with heterogeneous contrast located in the left upper abdomen around the stomach, spleen, pancreas, and left kidney on the horizontal (a) and coronal (b) images.](CRIS2018-4854368.001){#fig1}

![Magnetic resonance imaging (MRI) revealed a heterogeneously hyperintense mass on T1-weighted imaging (a), a relatively uniform and hyperintense mass on T2-weighted imaging (b), and a hypointense mass with an enhanced border on Gd-enhanced imaging (c).](CRIS2018-4854368.002){#fig2}

![The operative findings revealed a yellow mass covered with a thin layer that was located at the left side of the stomach, posteriorly to the transverse mesocolon and pancreas, on the cranial side of the left kidney.](CRIS2018-4854368.003){#fig3}

![An examination of the cut surface of this tumor revealed a multilobular yellow mass with bleeding in places.](CRIS2018-4854368.004){#fig4}

![A histopathological examination (×200) with hematoxylin and eosin staining revealed that tumor was composed of a proliferation of mature and variable-sized adipocytes admixed with aggregates of hematopoietic elements.](CRIS2018-4854368.005){#fig5}

###### 

Giant myelolipoma more than 1500 g without endocrine disorder.

  Number   Author             Year   Gender   Age   Site    Size (cm)           Weight (g)   Symptoms                                Ref. number
  -------- ------------------ ------ -------- ----- ------- ------------------- ------------ --------------------------------------- -------------
  1        Akamatsu           2004   Male     51    Right   31 × 24.5 × 11.5    6000         Abd. mass, abd. pain                    \[[@B6]\]
  2        Wilhelmus          1981   Female   70    Left    30 × 22 × 16        5500         Abd. mass, abd. pain                    \[[@B21]\]
  3        Mukherjee          2010   Male     56    Right   28 × 26 × 17        5500         Abd. mass, weight loss                  \[[@B22]\]
  4        Kumar              2015   Male     40    Right   38 × 20 × 16        5200         Abd. pain, dyspnea, dizziness           \[[@B23]\]
  5        Brogna             2011   Male     52    Left    25 × 20 × 20        4400         No                                      \[[@B24]\]
  6        O\'Daniel-Pierce   1996   Male     67    Right   30 × 20 × 11        4370         Abd. pain, abd. mass                    \[[@B25]\]
  7        Reshi              2007   Male     45    Right   25 × 14 × 11        \>4000       Abd. mass                               \[[@B26]\]
  8        Gautam             2013   Male     52    Right   28 × 18 × 12        3850         Abd. pain, headache                     \[[@B27]\]
  9        Tanaka             1998   Male     50    Right   30 × 25 × 23        3500         Abd. mass                               \[[@B28]\]
  10       Dell\'Avanzato     2009   Male     43    Right   22 × 18 × 9         3500         ND                                      \[[@B29]\]
  11       Saha               2015   Female   59    Left    23 × 16 × 9         3300         Abd. distension, dragging sensation     \[[@B30]\]
  12       Kumaresan          2011   Female   24    Right   30 × 20 × 18        3000         Abd. pain, abd. mass                    \[[@B31]\]
  13       Gerson             2015   Female   62    Right   21 × 18 × 9         2468         Abd. pain, nausea                       \[[@B32]\]
  14       Takahashi          2005   Male     48    Right   20 × 18 × 16        2400         Abd. distension, fever, diarrhea        \[[@B33]\]
  15       Fernandes          2010   Male     48    Right   28 × 20 × 15        2200         Abd. pain, abd. mass                    \[[@B34]\]
  16       Chand              2017   Male     35    Right   24 × 15 × 12        2000         Pain in the right thigh                 \[[@B35]\]
  17       Répássy            2001   Female   50    Right   20 × 14             1650         Abd. pain, abd. discomfort              \[[@B36]\]
  18       Andersom           2010   Man      35    Right   23.8 × 11.6 × 7.5   1575         Right-sided abd. discomfort             \[[@B37]\]
  19       Goldman            1996   Male     42    Right   20.5 × 15 × 8.5     1550         Right frank pain, dizziness, vomiting   \[[@B38]\]
  20       Ersoy              2006   Male     67    Right   12 × 10             1500         Abd. pain, fever                        \[[@B39]\]
  21       Chakrabarti        2012   Female   40    Right   15 × 10 × 8         1500         Abd. pain                               \[[@B40]\]
  22       Our case           2018   Female   62    Left    20 × 18 × 10        1500         Abd. mass                               

ND: not described in abstract.

###### 

Giant adrenal myelolipoma more than 1500 g with CAH.

  Number   Author        Year   Gender   Age   Site          Size (cm)                   Weight (g)   Symptoms                            Ref. number
  -------- ------------- ------ -------- ----- ------------- --------------------------- ------------ ----------------------------------- -------------
  1        Boudreaux     1979   Male     56                  34 × 24 × 10.5              5900         Dyspnea, low thoracic pain          \[[@B7]\]
  2        McGeoch       2012   Male     34    Left          23 × 19 × 11                5800         Adb. mass                           \[[@B41]\]
  3        Kale          2015   Male     51    Left          34 × 20 × 13                4700         Back pain                           \[[@B42]\]
  4        Alvarez       2014   Female   44    Left          26 × 24 × 9.5               5090         Abd. pain, nausea, bilious emesis   \[[@B43]\]
  5        Al-Bahri      2014   Male     39    Left, right   30 × 25 × 20 25 × 20 × 13   4100, 2700   Abd. distension, fatigue            \[[@B44]\]
  6        German-Mena   2011   Male     45    Left          24.4 × 19.0 × 9.5           2557         Abd. distension, abd. pain          \[[@B45]\]

CAH: congenital adrenal hyperplasia.
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